Literature DB >> 12834657

Smoking patterns and abstinence effects in smokers with no ADHD, childhood ADHD, and adult ADHD symptomatology.

Cynthia S Pomerleau1, Karen K Downey, Sandy M Snedecor, Ann M Mehringer, Judith L Marks, Ovide F Pomerleau.   

Abstract

Cigarette smokers are known to be overrepresented among adults with Attention Deficit Hyperactivity Disorder (ADHD). To date, however, no attempt has been made to determine the extent to which a lifetime diagnosis of ADHD may be associated with smoking even in the absence of current symptomatology. We hypothesized that nicotine dependence and abstinence effects-especially effects relevant to ADHD symptomatology-would be more pronounced in adult ADHD smokers in comparison with those who reported childhood ADHD symptoms only. Results indicated that, in contrast to controls without ADHD symptomatology, both adult and childhood ADHD groups were significantly more likely to experience a number of nicotine withdrawal symptoms, including irritability and difficulty concentrating; in no instance did the ADHD groups differ from one another in this regard. Thus, studying people with childhood symptoms of ADHD, even in the absence of an adult diagnosis, may shed light on the known association between smoking and ADHD.

Entities:  

Mesh:

Year:  2003        PMID: 12834657     DOI: 10.1016/s0306-4603(02)00223-x

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  43 in total

1.  Anxiety and Depressed Mood Decline Following Smoking Abstinence in Adult Smokers with Attention Deficit Hyperactivity Disorder.

Authors:  Lirio S Covey; Mei-Chen Hu; Theresa Winhusen; Jennifer Lima; Ivan Berlin; Edward Nunes
Journal:  J Subst Abuse Treat       Date:  2015-07-17

Review 2.  Nicotine and hippocampus-dependent learning: implications for addiction.

Authors:  Thomas J Gould
Journal:  Mol Neurobiol       Date:  2006-10       Impact factor: 5.590

3.  Atomoxetine reverses nicotine withdrawal-associated deficits in contextual fear conditioning.

Authors:  Jennifer A Davis; Thomas J Gould
Journal:  Neuropsychopharmacology       Date:  2007-01-17       Impact factor: 7.853

4.  Associations between Cloninger's temperament dimensions and acute tobacco withdrawal.

Authors:  Adam M Leventhal; Andrew J Waters; Susan Boyd; Eric T Moolchan; Stephen J Heishman; Caryn Lerman; Wallace B Pickworth
Journal:  Addict Behav       Date:  2007-06-09       Impact factor: 3.913

5.  ADHD symptoms, autistic traits, and substance use and misuse in adult Australian twins.

Authors:  Duneesha De Alwis; Arpana Agrawal; Angela M Reiersen; John N Constantino; Anjali Henders; Nicholas G Martin; Michael T Lynskey
Journal:  J Stud Alcohol Drugs       Date:  2014-03       Impact factor: 2.582

Review 6.  ADHD and smoking: from genes to brain to behavior.

Authors:  Francis Joseph McClernon; Scott Haden Kollins
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

7.  Relationship between cigarette smoking and childhood symptoms of inattention and hyperactivity/impulsivity in alcohol-dependent adults without attention-deficit hyperactivity disorder.

Authors:  Jaimee L Heffner; Candace S Johnson; Thomas J Blom; Robert M Anthenelli
Journal:  Nicotine Tob Res       Date:  2010-01-18       Impact factor: 4.244

8.  Symptom dimensions of attention deficit hyperactivity disorder and nicotine withdrawal symptoms.

Authors:  Katherine J Ameringer; Adam M Leventhal
Journal:  J Addict Dis       Date:  2012

9.  Effects of smoking abstinence on smoking-reinforced responding, withdrawal, and cognition in adults with and without attention deficit hyperactivity disorder.

Authors:  Scott H Kollins; Joseph S English; Michelle E Roley; Benjamin O'Brien; Justin Blair; Scott D Lane; F Joseph McClernon
Journal:  Psychopharmacology (Berl)       Date:  2012-12-18       Impact factor: 4.530

Review 10.  The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum.

Authors:  Sharon R Grady; Outi Salminen; Duncan C Laverty; Paul Whiteaker; J Michael McIntosh; Allan C Collins; Michael J Marks
Journal:  Biochem Pharmacol       Date:  2007-07-27       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.